glimepiride has been researched along with 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, S; Ishikawa, SE; Kawakami, M; Kuroki, M; Saito, M; Ueba, H; Umemoto, T; Yasu, T | 1 |
| Cao, J; E, L; Gu, B; Liu, H; Ma, J; Ma, P; Wu, X | 1 |
| Geng, W; Gu, B; Li, J; Liu, H; Ma, P; Tan, B; Xiong, W | 1 |
3 other study(ies) available for glimepiride and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
| Article | Year |
|---|---|
Glimepiride induces nitric oxide production in human coronary artery endothelial cells via a PI3-kinase-Akt dependent pathway.
Topics: Cells, Cultured; Chromones; Coronary Vessels; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Glyburide; Humans; Hypoglycemic Agents; Morpholines; Nitric Oxide; Oligodeoxyribonucleotides, Antisense; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Signal Transduction; Sulfonylurea Compounds | 2005 |
Glimepiride induces proliferation and differentiation of rat osteoblasts via the PI3-kinase/Akt pathway.
Topics: Alkaline Phosphatase; Animals; Biomarkers; Blotting, Western; Cell Differentiation; Cell Proliferation; Chromones; Coloring Agents; Enzyme Inhibitors; Hypoglycemic Agents; Morpholines; Oncogene Protein v-akt; Osteoblasts; Phosphatidylinositol 3-Kinases; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds; Tetrazolium Salts; Thiazoles | 2010 |
Glimepiride promotes osteogenic differentiation in rat osteoblasts via the PI3K/Akt/eNOS pathway in a high glucose microenvironment.
Topics: Alkaline Phosphatase; Animals; Apoptosis; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chromones; Core Binding Factor Alpha 1 Subunit; Down-Regulation; Glucose; Hypoglycemic Agents; Morpholines; Nitric Oxide Synthase Type III; Osteoblasts; Osteocalcin; Osteogenesis; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Sulfonylurea Compounds | 2014 |